Evotec, Genentech Form Drug Discovery Alliance
Evotec will apply its integrated and innovative drug discovery platform in combination with its disease biology expertise against targets nominated by Genentech. This will include assay development and high throughput screening, medicinal chemistry and structural biology.
The aim of the collaboration is to deliver high quality leads and development candidates to support Genentech's research efforts. Further commercial details were not released.
Werner Lanthaler, CEO of Evotec, said: “We are proud that Genentech has selected Evotec's scientists and drug discovery platform to support their research efforts. We look forward to working closely with Genentech's scientists and achieving success together.”
How far this alliance will benefit both the companies?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.